Clinical trial
The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-infected…
NCT00145561 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00145561 |
|---|---|
| Title | The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-infected Pregnant Women. |
| Official title | The Pharmacokinetics of SAquinavir (Invirase New Tablet Formulation) 1,000mg + Ritonavir (Norvir) 100mg q12h in HIV-infected Pregnant Women (SARA) |
| Lead sponsor | Radboud University Medical Center, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Saquinavir and Ritonavir |
| Enrollment | 40 |
| Start date | Aug 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Sep 5, 2005 |
| Last update posted | Oct 19, 2020 |
| Countries | Germany, Netherlands, Spain, Thailand, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: